EDGAR Filing Documents for 0001180603-06-000001

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001180603-06-000001

Filing Date

2006-01-04

Accepted

2006-01-04 11:52:03

Documents

Period of Report

2006-01-03

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	3205
	Complete submission text file	0001180603-06-000001.txt		5040

Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412

Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081

PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O RED HAT, INC 1801 VARSITY DRIVE RALEIGH NC 27606

Business Address 9197543300 X44403

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 06505407